Impact of guidelines implemented in a Paris university hospital: Application to the use of antiemetics by cancer patients

British Journal of Clinical Pharmacology

Volumn 48, Issue 4, 1999, Pages 616-622

  Debrix, I ^a   Flahault, A ^a   Becker, A ^a   Schwartz, L ^b   Kanfer, A ^a   Milleron, B ^a  

^a HÔPITAL TENON   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

Antiemetics; Delphi technique; Drug utilization review; Impact of guidelines

Indexed keywords

ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT;

ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; NAUSEA; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; UNIVERSITY HOSPITAL; VOMITING;

ACADEMIC MEDICAL CENTERS; ANTIEMETICS; DELPHI TECHNIQUE; HUMANS; MEDICAL ERRORS; NEOPLASMS; PALLIATIVE CARE; PARIS; PRACTICE GUIDELINES; PRESCRIPTIONS, DRUG; SEROTONIN ANTAGONISTS; TIME FACTORS; VOMITING;

EID: 0032854919     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1999.00048.x     Document Type: Article

References (17)

1. 1 Milholland AV, Wheeler SG, Heieck JJ. Medical assessment by a Delphi group opinion technic. N Engl J Med 1973; 288: 1272-1275.
2. 2 Pill J. The Delphi method: Substance, context, a critique and an annotated bibliography. Socio Econ Plan Sci 1971; 5: 57-71.
3. 3 Gabbay J, Francis L. How much day care surgery ? Delphic predictions. Br Med J 1988; 297: 1249-1252.
4. 4 Koplan JP, Farer LS. Choice of preventive treatment for Isoniazid-resistant tuberculosis infection. Use of decision analysis and the Delphi technique. JAMA 1980; 244: 2736 2740.
5. 5 Field MJ, Lohr KN, eds. Guidelines for Clinical Practice From Development to Use National Academy of Sciences USA 1992.
6. 6 Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 1993; 342: 1317-1322.
7. 7 Grimshaw JM, Russel IT. Achieving health gain through clinical guidelines II. Ensuring guidelines change medical practice. Qual Health Care 1994; 3: 45-52.
8. 8 Morgan AS, Brennan PJ, Fishman. Impact of a Vancomycin restriction policy on use and cost of Vancomycin and incidence of Vancomycin-resistant enterococcus. Ann Pharmacother 1997; 31: 970-973.
9. 9 Ray-Coquard I, Philip T, Lehmann M, Fervers B, Farsi F, Chauvin F. Impact of a Clinical Guidelines Program of Breast and Colon Cancer in a French Cancer Center. JAMA 1997; 278: 1591-1595.
10. 10 Boath E, Mucklow J, Black P. Consulting the oracle: a Delphi study to determine the content of a postgraduate distance learning course in therapeutics. Br J Clin Pharmacol 1997; 43: 643-647.
11. 11 Laszlo J. Nausea and vomiting as major complications of cancer chemotherapy. Drugs 1983; 25(Suppl 1): 1-7.
12. 12 Craig JB, Powell BD. Review: The management of nausea and vomiting in clinical oncology. Am J Med Sci 1987; 293: 33-44.
13. 13 Lindley CM, Bernard S, Fields SM. Incidence and duration of chemotherapy-induced nausea and vomiting in the outpatient oncology population. J Clin Oncol 1989; 7: 1142-1149.
14. 14 Ruff P, Paska W, Goedhals L, et al. Ondansetron compared with granisetron in the prophylaxis of cisplatin-induced acute emesis: a multicentre double-blind, randomised, parallel-group study. Oncology 1994; 54: 113-118.
15. 15 Roila F, Tonato M, Cognetti F, et al. Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone. J Clin Oncol 1991; 9: 675-678.
16. 16 Dunn WR, Hamilton DD, Harden RM. Techniques of identifying competences needed of doctors. Med Teacher 1985; 7: 15-25.
17. 17 McKee M, Priest P, Ginzler M, Black N. How representative are members of experts panels? Quality Assurance Health Care 1991; 3: 89-94.